CLASS II Drug recall · Reported 31 Jan 2018 · FDA Enforcement Report

Pravastatin Sodium Tablets, USP, 10 mg recalled

International Laboratories is recalling Pravastatin Sodium Tablets, USP, 10 mg, distributed nationwide in the US. The recall was initiated on 12 Jan 2018 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot: 117093A, Exp. 06/19
Quantity recalled9,052 cartons

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0233-2018
FDA event ID
78939
Recalling firm
International Laboratories, Seminole, FL
Classification
Class II
Status
Terminated
Recall initiated
12 Jan 2018
FDA classified
24 Jan 2018
Reported
31 Jan 2018
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Packaging Defects

Timeline

12 Jan 2018Recall initiated by company
24 Jan 2018Classified by FDA+12 days
31 Jan 2018Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Presence of Foreign Tablets/Capsules: bottles could contain both pravastatin sodium 10 mg and 20 mg tablets in the same bottle.

Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.

Product as listed by the FDA

Pravastatin Sodium Tablets, USP, 10 mg, 30-count bottles, packaged in 12 x 30 tablets for individual patient dispensing per pharmacy dispenser cartons, Rx only, Packaged for: International Laboratories, LLC. St. Petersburg, FL 33710, NDC 54458-927-16.

Where it was distributed

Nationwide in the USA

Nationwide

Questions about this recall

Is Pravastatin Sodium Tablets, USP, 10 mg recalled?

Yes. International Laboratories recalled Pravastatin Sodium Tablets, USP, 10 mg on 12 Jan 2018. The recall is Class II and its status is Terminated. Recall number D-0233-2018.

Why was it recalled?

Presence of Foreign Tablets/Capsules: bottles could contain both pravastatin sodium 10 mg and 20 mg tablets in the same bottle.

Which lots are affected?

Lot: 117093A, Exp. 06/19

Where was it sold?

Nationwide in the USA

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from International Laboratories

All 4

Other Pravastatin recalls

All 17